Loading
The Global Burden of Disease collaboration's count for 2015: about 17.5 million new cancer cases worldwide, with cases rising by a third over the previous decade mostly because populations were growing and ageing, and lung cancer the largest cause of years of life lost to cancer.
The Global Burden of Disease Cancer Collaboration estimated incidence, mortality, years of life lost, years lived with disability and disability-adjusted life-years for 32 cancer groups in 195 countries for 2015 and the trend since 2005. It counted about 17.5 million cases and 8.7 million deaths. Cases increased by 33% between 2005 and 2015, of which most was attributable to population ageing and growth rather than to rising age-specific rates. Tracheal, bronchus and lung cancer was the leading cause of cancer disability-adjusted life-years globally.
GBD is the other major global cancer count alongside GLOBOCAN, using different methods, and its burden measures in years of life lost make the case that cancer control is largely a problem of ageing populations in middle-income countries.
Shares Sung 2021: GLOBOCAN 2020, the year breast cancer overtook lung cancer as the most diagnosed cancer, Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance, Non-small-cell lung cancer.
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance.